| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aad15cdfb05597c84c73889ea0703b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
2019-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d32da0cca5558dbbb8179253f7bafa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ee86a6de7a1634ba114f4fe7130abdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cbcca7e556e9ef97fc27dc3dbf61eb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e03aff260b76ba9eb07248b38d015338
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2280298356c28c156cc11c2d3f001304
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39e95bf0f2213b82a9a20f6d6b3bfc21 |
| publicationDate |
2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111936512-A |
| titleOfInvention |
Anticoagulant proteins and their use in the treatment of diseases associated with neutrophil activation |
| abstract |
The present invention relates to proteins or polypeptides comprising I. ricinus salivary gland polypeptides, fragments or variants thereof, and their use in inhibiting the extrinsic coagulation pathway and treating and/or preventing neutralization after activation of the extrinsic coagulation pathway Use in diseases and disorders associated with the recruitment and activation of granulocytes. In particular, the present invention relates to proteins comprising I. ricinus salivary gland polypeptides, fragments or variants thereof for the treatment and/or prevention of any thrombosis associated with the recruitment and activation of neutrophils following activation of the extrinsic coagulation pathway The purpose of the event. |
| priorityDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |